Suppr超能文献

从人脐带血中的造血干/祖细胞在 MS-5 基质细胞系制备的脱细胞支架上的体外扩增。

Ex vivo expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS-5 stromal cell line.

机构信息

CSIR Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India; Deakin University, Waurn Ponds, Geelong, VIC, Australia.

出版信息

J Tissue Eng Regen Med. 2013 Nov;7(11):871-83. doi: 10.1002/term.1479. Epub 2012 Apr 17.

Abstract

Lineage-specific expansion of haematopoietic stem/progenitor cells (HSPCs) from human umbilical cord blood (UCB) is desirable because of their several applications in translational medicine, e.g. treatment of cancer, bone marrow failure and immunodeficiencies. The current methods for HSPC expansion use either cellular feeder layers and/or soluble growth factors and selected matrix components coated on different surfaces. The use of cell-free extracellular matrices from bone marrow cells for this purpose has not previously been reported. We have prepared insoluble, cell-free matrices from a murine bone marrow stromal cell line (MS-5) grown under four different conditions, i.e. in presence or absence of osteogenic medium, each incubated under 5% and 20% O₂ tensions. These acellular matrices were used as biological scaffolds for the lineage-specific expansion of magnetically sorted CD34⁺ cells and the results were evaluated by flow cytometry and colony-forming assays. We could get up to 80-fold expansion of some HSPCs on one of the matrices and our results indicated that oxygen tension played a significant role in determining the expansion capacity of the matrices. A comparative proteomic analysis of the matrices indicated differential expression of proteins, such as aldehyde dehydrogenase and gelsolin, which have previously been identified as playing a role in HSPC maintenance and expansion. Our approach may be of value in identifying factors relevant to tissue engineering-based ex vivo HSPC expansion, and it may also provide insights into the constitution of the niche in which these cells reside in the bone marrow.

摘要

从人类脐带血(UCB)中分离出特定谱系的造血干/祖细胞(HSPCs)是可取的,因为它们在转化医学中有多种应用,例如治疗癌症、骨髓衰竭和免疫缺陷。目前用于 HSPC 扩增的方法使用细胞饲养层和/或可溶性生长因子以及涂覆在不同表面上的选定基质成分。迄今为止,尚未有报道将骨髓细胞的无细胞细胞外基质用于此目的。我们已经从在四种不同条件下生长的鼠骨髓基质细胞系(MS-5)中制备了不溶性的无细胞基质,即在存在或不存在成骨培养基的情况下,每种情况下均在 5%和 20%O₂张力下孵育。这些无细胞基质被用作磁性分选的 CD34⁺细胞的谱系特异性扩增的生物支架,并通过流式细胞术和集落形成测定进行评估。我们可以在其中一种基质上获得高达 80 倍的某些 HSPC 扩增,我们的结果表明氧张力在确定基质的扩增能力方面起着重要作用。基质的比较蛋白质组学分析表明,醛脱氢酶和凝胶蛋白等蛋白质的表达存在差异,这些蛋白质先前已被确定在 HSPC 维持和扩增中发挥作用。我们的方法可能有助于确定与基于组织工程的体外 HSPC 扩增相关的因素,并且还可能深入了解这些细胞在骨髓中所处的龛位的构成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验